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Background: Endoscopic mucosal resection (EMR) is simple and quick and has low complication rates. However,
the disadvantage of local recurrence or remnant rate limits the use of this technique. We aimed to analyse the
outcomes of conventional EMR and EMR with circumferential incision (CIEMR), a simplified modification of EMR,
in the endoscopic treatment of rectal carcinoid tumours.
Methods: A total of 59 consecutive patients with rectal carcinoid tumours without regional lymph node
enlargement confirmed by endoscopic ultrasonography were included in the study. These patients underwent
endoscopic treatment from January 2009 to September 2011 and were randomly designated into CIEMR (n = 31)
or EMR group (n = 28). En bloc resection rate, pathological complete resection rate, procedure time, complications
and follow-up outcomes were analysed.
Results: The en bloc resection rate was not significantly different between the CIEMR and EMR groups (100% versus
96.55%, P > 0.05). The pathological complete resection rate was higher in the CIEMR group than in the EMR group
(96.7% versus 82.14%, P < 0.05). The overall complication rate, delayed bleeding and procedure time were not
significantly different between the two groups. No recurrence was observed in either the EMR or CIEMR group.
Conclusions: CIEMR optimises the procedure of EMR and simplifies the technique of endoscopic submucosal
dissection; thus, it has a better histologically complete resection rate and more acceptable complication rate than EMR.
Thus, CIEMR may be preferable to conventional EMR for resection of rectal carcinoid tumours less than 15 mm.
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Carcinoid tumour is a slow-growing type of neuro-endo-
crine tumour that originates in the cells of the neuro-
endocrine system [1]. Over two-thirds of carcinoid tumours
are found in the gastrointestinal tract [2]. Rectal carcinoid
tumours are uncommon, representing 1.1% to 1.3% of all
rectal neoplasms [3,4]. Most rectal carcinoid tumours are
asymptomatic and found during screening colonoscopy.
The surgical treatment for carcinoid tumours is generally
dictated to a degree, but not absolutely, by size [5]. Tu-
mours less than 1 cm in diameter are rarely associated
with metastatic disease. Tumours measuring from 1.0 cm
to 1.9 cm in diameter tend to show a metastatic rate of 4%* Correspondence: yunshengyangcn@163.com
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unless otherwise stated.to 30% [6,7]. Lymph node or liver metastases are observed
in over 80% of tumours measuring more than 2 cm in
diameter. Therefore, small rectal carcinoid tumours are
usually managed with local excision including endoscopic
techniques [8,9].
Endoscopic mucosal resection (EMR) is generally per-
formed for gastrointestinal lesions because of its simplicity,
quick operation and low complication rates [10-13]. How-
ever, locally recurrent or remnant tumours after EMR of
gastrointestinal tumours have been increasingly reported
[14,15], coinciding with increased use of EMR. EMR could
be used to complete resection of mucosal lesions less than
2 cm, and rectal carcinoid tumours suitable for endoscopic
treatment are generally less than 2 cm, but lateral and verti-
cal margin involvement has recently been reported [16].
Endoscopic submucosal dissection (ESD) is a therapeutic
technique used to treat gastrointestinal neoplasms with aLtd. This is an Open Access article distributed under the terms of the Creative
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used to treat rectal carcinoid tumours in China because
of its technical difficulty, longer procedure time and
increased risk of perforation. Circumferential incision
is one of the procedures of ESD. Hirao et al. [17] first
reported EMR with circumferential incision (CIEMR)
in 1986. The application of CIEMR in early gastric cancer
has been previously reported [18,19]. CIEMR reduced
the operative time and avoided the risk of perforation
for lesions less than 2 cm.
The present study compared CIEMR with EMR for the
treatment of rectal carcinoid tumours. En bloc resection
rate, histological complete resection rate, complications,
resection time and follow-up outcomes were measured to
determine an effective and simple treatment approach for
rectal carcinoid tumours. The aim of this study was to
assess the outcomes of conventional EMR and CIEMR in
the endoscopic treatment of rectal carcinoid tumours.
Methods
Patients
Conventional EMR and CIEMR were performed on 59
lesions in 59 patients with rectal carcinoid tumours.
These treatments were carried out at the Chinese PLA
General Hospital, Beijing, China between January 2009
and September 2011. The patients were randomly divided
into CIEMR (n = 31) or EMR groups (n = 28). All patients
were asymptomatic, and all tumours were found inci-
dentally on screening colonoscopy. The inclusion criterion
was patients with rectal carcinoid tumours less than
15 mm without significant evidence of regional lymph
node enlargement on computer tomography (CT) scan-
ning or endoscopic ultrasonography (EUS). All lesions
were diagnosed by EUS as tumours in the submucous
layer and confirmed by histological evaluation of endo-
scopic biopsy specimens before EMR/CIEMR. Rectal
carcinoid tumours with distant metastases to the liver
or lung on CT scans were excluded. Two experienced
endoscopists (LZS and HJ) performed all EMR/CIEMR
procedures. Informed consent was obtained from each
patient. All aspects of this study were approved by the
medical ethical committee of the Chinese PLA General
Hospital.
The endpoint of the present study was the differences
of clinical efficacy between CIEMR and EMR, the variables
evaluated included en bloc resection rate and pathological
complete resection rate, as well as procedure time, compli-
cations and follow-up outcomes.
CIEMR and conventional EMR procedures
A single-accessory channel endoscope (GIF-Q260J;
Olympus, Tokyo, Japan) was used during the proced-
ure. A short transparent cap was attached to the tip
of the endoscope (ND-201-11802, Olympus, Tokyo, Japan).An electrosurgical current generator (VIO200, ERBE,
Tubingen, Germany) was used for endoscopic treatment.
CIEMR was performed as follows (Figure 1): 1) marking
dots were made approximately 2 mm to 3 mm outside
the lesion with a dual knife (KD-650Q, Olympus, Tokyo,
Japan); 2) a solution (250 mL fructose-glycerol (Chia
Tai Fenghai Pharmaceutical Co., JS, China) + 1 mL epi-
nephrine + 0.3 mL methylthioninium chloride) was sub-
mucosally injected around the lesion using a needle
(INJ1-A1-07-5-23-180, Medwork, Neuss, Germany). After
the injection, only the mucosa was lifted off the muscularis
propria layer; 3) then, the mucosa was incised outside the
marker dots using a dual knife; 4) the tumour was resected
with a snare. The visibly exposed vessels on the artificial
ulcer were coagulated with a Coagrasper (FD-410LR,
Olympus, Tokyo, Japan) or argon plasma coagulation
to prevent delayed bleeding. CIEMR resection time was
counted from the time of making the marking dots to
the completion of resection.
Conventional EMR procedure in this study was per-
formed by ER-cap technique. An ER kit (Olympus, Tokyo,
Japan) was used, which contains a spraying catheter, an
injection needle, a hard oblique cap (inner 12 mm) and
a crescent-shaped snare. The cap was attached to the tip
of the endoscope, and the endoscope was reintroduced.
The lesion was initially lifted by submucosal injection.
Then, the snare was prelooped in the distal rim of the cap,
and the mucosa was sucked into the cap before the snare
was tightened. Resection time of conventional EMR was
defined as the time from the submucosal injection to the
completion of resection.Histopathological evaluation
Specimens were microscopically examined for histopatho-
logical type, invasion depth, lateral and vertical resection
margins and lymphovascular involvement. En bloc resec-
tion referred to resection of the entire tumour in one piece
rather than piecemeal. The histopathologic evaluation of
gastrointestinal neuro-endocrine neoplasm in this study
was NET - G1 according to the World Health Organ-
ization (WHO) 2010 classification of tumors of the digest-
ive system.
A pathological complete resection was defined as an
en bloc resection with no lateral and vertical margin
involvement of the resected specimen and no lympho-
vascular invasion.Follow-up
The patients were followed-up by colonoscopy at 3, 6
and 12 months and then annually thereafter. The patients
with vertical or lateral resection margin involvement were
recommended for additional surgery and followed-up with
chest radiography and abdominal-pelvic CT scanning.
Figure 1 Endoscopic mucosal resection with circumferential incision of a rectal carcinoid tumour. (A) Conventional endoscopic view
showing a carcinoid tumour in the rectum; (B) Endoscopic ultrasonography (EUS) image showing the lesion not to invade the muscularis propria
layer; (C) Marking dots made around the lesion; (D) Circumferential incision around the dots; (E) Snaring after circumferential incision; (F) Region
after endoscopic mucosal resection with circumferential incision; (G) Resected specimen; (H) Histologic view of a rectal carcinoid tumor obtained
by endoscopic submucosal dissection (ESD) (H&E stain; ×40).
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Statistical analysis was performed by using SPSS software
(version 12.0; SPSS Inc, Chicago, IL, USA). Significant
difference between the two groups was analyzed using
Fisher exact test and Mann–Whitney U-test. P < 0.05
was considered significant for two-tailed tests.
Results
Characteristics of patients and tumours
Sex and age distribution were similar in conventional EMR
and CIEMR groups (31 CIEMR and 28 EMR). The endo-
scopically estimated diameter of rectal carcinoid tumours
was 3 mm to 15 mm in both groups. The histologically
measured sizes of the resected specimens were similar
to the endoscopically estimated diameters. Table 1 shows
the characteristics of the two groups.
Outcomes of CIEMR/EMR
The clinical outcomes of the CIEMR and EMR groups
are shown in Table 2. The en bloc resection rate was notTable 1 Characteristics of patients and tumours
CIEMR EMR P-value




Tumor size (mm)a 0.73
Mean ± SD 9 ± 2.5 8 ± 3.3
Range 3 to 15 3 to 15
Distance from the anal verge (cm) 6.1 ± 2.5 6.2 ± 3.0 0.67
CIEMR, conventional endoscopic mucosal resection with
circumferential incision.
EMR, endoscopic mucosal resection.
aTumour size was determined by pathological findings.significantly different between the two groups (P > 0.05)
(Figure 2). The pathological complete resection rate
was higher in the CIEMR group than in the EMR group
(P < 0.05). Lateral resection margin involvement was
observed in three cases (10.3%) in the EMR group but
not in the CIEMR group. Vertical resection margin
involvement was observed in two cases (6.9%) in the
EMR group versus one in the CIEMR group (3.3%). No
lymphovascular invasion occurred in either the CIEMR
or EMR group. The median CIEMR operative time and
EMR operative time were 7.6 minutes (range, 5 minutes
to 13 minutes) and 4.2 minutes (range, 2 minutes to
10 minutes), respectively.
Complications
No perforations or delayed bleeding occurred in any
xpatient of both groups. Procedure-related bleeding
occurred in all CIEMR cases and in 21 of 28 of EMR
cases, but haemostasis was achieved by endoscopic treat-
ment. None of the patients required blood transfusion.Table 2 Clinical outcomes of circumferential incision
endoscopic mucosal resection (CIEMR) and endoscopic
mucosal resection (EMR)
CIEMR EMR P-value
En bloc resection, n (%) 100 96.55 0.747
Pathologic complete resection, n (%) 96.7 82.14 0.043
Resection time (minutes) 7.6 4.2 0.028
Complication, n (%)
Delayed bleeding 0 0 1
Perforation 0 0 1
Follow-up 19.1(8.6) 18.3(7.9) 0.588
CIEMR, endoscopic mucosal resection with circumferential incision.
EMR, endoscopic mucosal resection.
Figure 2 Incomplete resection using endoscopic mucosal
resection (EMR). (A) Conventional endoscopic view showing a
carcinoid tumour in the rectum; (B) Endoscopic ultrasonography
(EUS) image showing the lesion in the muscularis propria layer; (C)
Snaring after submucosal injection; (D) Remnant carcinoid tumour
on post-EMR ulcer (red arrow).
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the EMR and CIEMR groups (P = 1.00).
Follow-up outcomes
No local recurrence occurred during a median follow-up
period of 20 months (range, 3 months to 35 months) in
patients with pathological complete resection in both
the CIEMR and EMR groups. An incomplete pathological
resection was found in five patients of the EMR group.
Six patients with vertical and lateral resection margin
involvement were converted to open surgery. Postoper-
ative pathological diagnosis was positive for carcinoid
in two patients in the EMR groups. No local remnant
lesion was observed during the median follow-up period
of 17 months (range, 3 months to 30 months).
Discussion
EMR is a safe and useful endoscopic strategy for small
and superficial neoplasms confined to the mucosa or
superficial submucosa in the colorectum. However, the
high recurrence rate of residual lesions is a restrictive
factor for EMR application. ESD, devoid of the disad-
vantages of EMR, is performed to locally treat small rectal
carcinoid tumours to achieve complete resection rates,
but the entire ESD is difficult and the complication rate
is high. This study performed CIEMR in rectal carcinoid
tumours and compared the clinical outcomes between
CIEMR and EMR.
Patients with rectal carcinoid tumours not larger than
15 mm were chosen in this study. Given that most rectal
carcinoid tumours that we detected were small, the resultagreed well with that reported in the literature [20].
Metastasis is reported to occur in 5% to 15% of carcinoid
tumours measuring 10 mm to 19 mm, and the frequency
increases to over 80% for tumours sized 20 mm or larger
[21]. ESD was performed in patients with rectal carcinoid
tumours larger than 15 mm in our hospital. The en bloc
resection rate was not significantly different between the
CIEMR group and the EMR group because the lesion size
was small. CIEMR is a modification on EMR that involves
the circumferential incision procedure of ESD to ensure a
safe margin. Lateral resection margin involvement was
observed in three cases in the EMR group versus none
in the CIEMR group. Although the procedure time of
CIEMR seemed significantly longer than that of EMR
(7.6 minutes versus 4.2 minutes) because of marking,
circumferential resection and other extra steps, the mean
resection time (7.6 minutes) was acceptable. In this study,
the complication rate in the CIEMR group was similar to
that in the EMR group. No perforation occurred in either
group, probably because the lesions were small. Intraoper-
ative bleeding was successfully managed by endoscopic
treatment, and no delayed bleeding occurred.
Compared with conventional EMR, the advantage of
CIEMR is risk reduction of residual tumours because the
side margin of the lesion is clearly exposed after circum-
ferential incision. Given that residual or recurrent tumours
usually develop from remnant tumour tissues from the
resected margin, determining the lateral margin blindly
and confirming the presence or absence of any residual
tumour after resection because of ablation are difficult for
conventional EMR. After circumferential incision, the
snare can be easily placed along the incision, and the
tumour margin can be reliably cut. But the disadvantage
of CIEMR is the longer procedure time versus EMR.
Compared with ESD, CIEMR procedure is easier because
submucosal dissection, one of the most difficult ESD pro-
cedures, is omitted. Snaring becomes simple and safe after
circumferential incision. And the procedure time of
CIEMR is shortened and the risk of complications such
as perforation is reduced.
The first limitation of this study is the single-centre
design. More experience from other centres is necessary
to define the indication for CIEMR. Second, CIEMR or
EMR was only performed in rectal carcinoid tumours.
Considering that the rectum is wide and fixed and has
fewer mucosal folds, endoscopic manoeuvrability in the
rectal area is usually better than that in other locations
of the gastrointestinal tract. Third, the follow-up period
was not sufficiently long. Finally, outcomes after CIEMR
and EMR were analysed in this research, but ESD has
been found feasible for the treatment of rectal carcinoid
tumours in many studies [16,22-24]. In the future, we will
compare ESD with CIEMR for the endoscopic treatment
of rectal carcinoid tumours.
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In conclusion, CIEMR optimises the procedure of EMR
and simplifies the technique of ESD. This method shows
better histologically complete resection rate and more
acceptable complication rate than EMR. CIEMR is a good
alternative to EMR for en bloc resection of rectal carcinoid
tumours less than 15 mm in diameter.
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